1. Steroid binding to Autotaxin links bile salts and lysophosphatidic acid signalling.
- Author
-
Keune WJ, Hausmann J, Bolier R, Tolenaars D, Kremer A, Heidebrecht T, Joosten RP, Sunkara M, Morris AJ, Matas-Rico E, Moolenaar WH, Oude Elferink RP, and Perrakis A
- Subjects
- Animals, Bile Acids and Salts chemistry, Crystallography, X-Ray, HEK293 Cells, HeLa Cells, Humans, Hydroxycholesterols chemistry, Hydroxycholesterols metabolism, Kinetics, Lysophospholipids chemistry, Models, Molecular, Molecular Conformation, Molecular Structure, Phosphoric Diester Hydrolases chemistry, Protein Binding, Protein Structure, Tertiary, Rats, Receptors, Lysophosphatidic Acid metabolism, Steroids chemistry, Taurochenodeoxycholic Acid chemistry, Taurochenodeoxycholic Acid metabolism, Bile Acids and Salts metabolism, Lysophospholipids metabolism, Phosphoric Diester Hydrolases metabolism, Signal Transduction, Steroids metabolism
- Abstract
Autotaxin (ATX) generates the lipid mediator lysophosphatidic acid (LPA). ATX-LPA signalling is involved in multiple biological and pathophysiological processes, including vasculogenesis, fibrosis, cholestatic pruritus and tumour progression. ATX has a tripartite active site, combining a hydrophilic groove, a hydrophobic lipid-binding pocket and a tunnel of unclear function. We present crystal structures of rat ATX bound to 7α-hydroxycholesterol and the bile salt tauroursodeoxycholate (TUDCA), showing how the tunnel selectively binds steroids. A structure of ATX simultaneously harbouring TUDCA in the tunnel and LPA in the pocket, together with kinetic analysis, reveals that bile salts act as partial non-competitive inhibitors of ATX, thereby attenuating LPA receptor activation. This unexpected interplay between ATX-LPA signalling and select steroids, notably natural bile salts, provides a molecular basis for the emerging association of ATX with disorders associated with increased circulating levels of bile salts. Furthermore, our findings suggest potential clinical implications in the use of steroid drugs.
- Published
- 2016
- Full Text
- View/download PDF